3.81 USD
+0.16 (+4.38%)
3.88 USD
+0.07 (+1.84%)
ChartMill assigns a Buy % Consensus number of 80% to CLRB. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 47.94. This target is 1158.27% above the current price.
- CLRB was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about CLRB.
- In the previous month the buy percentage consensus was at a similar level.
- CLRB was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-14 | Maxim Group | Downgrade | Buy -> Hold |
| 2024-12-11 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2024-11-19 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-11 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-28 | Roth MKM | Maintains | Buy -> Buy |
| 2024-03-28 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-04 | Roth MKM | Reiterate | Buy -> Buy |
| 2022-11-04 | HC Wainwright & Co. | Maintains | Buy |
CELLECTAR BIOSCIENCES INC / CLRB FAQ
What do analysts expect the price target to be for CELLECTAR BIOSCIENCES INC (CLRB)?
10 analysts have analysed CLRB and the average price target is 47.94 USD. This implies a price increase of 1158.27% is expected in the next year compared to the current price of 3.81.
What is the consensus rating for CELLECTAR BIOSCIENCES INC (CLRB) stock?
The consensus rating for CELLECTAR BIOSCIENCES INC (CLRB) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover CELLECTAR BIOSCIENCES INC (CLRB) stock?
The number of analysts covering CELLECTAR BIOSCIENCES INC (CLRB) is 10.